Extended Dosing Intervals Possible With Aflibercept in Diabetic Macular Edema

(MedPage Today) -- Positive 3-year results from the phase III PHOTON study were presented at the recent American Academy of Ophthalmology (AAO) meeting, demonstrating that patients with diabetic macular edema (DME) achieved sustained vision improvements...